Scarica l'app Stockscreener
5.18
0.00%
0.00
Pre-mercato:
5.13
-0.05
-0.97%
Precedente Chiudi:
$5.18
Aprire:
$5.2
Volume 24 ore:
798.48K
Relative Volume:
0.49
Capitalizzazione di mercato:
$657.40M
Reddito:
$433.14M
Utile/perdita netta:
$4.95M
Rapporto P/E:
145.10
EPS:
0.0357
Flusso di cassa netto:
$6.55M
1 W Prestazione:
-11.75%
1M Prestazione:
+0.00%
6M Prestazione:
+41.53%
1 anno Prestazione:
+61.87%
Intervallo 1D:
$5.115
$5.35
Intervallo di 1 settimana:
$5.04
$5.70
Portata 52W:
$2.6101
$7.0771
Organogenesis Holdings Inc Stock (ORGO) Company Profile
Nome
Organogenesis Holdings Inc
Settore
Telefono
781-575-0775
Indirizzo
85 DAN ROAD, CANTON, MA
Confronta ORGO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ORGO
Organogenesis Holdings Inc
|
5.18 | 657.40M | 433.14M | 4.95M | 6.55M | 0.0357 |
|
ZTS
Zoetis Inc
|
125.82 | 55.71B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.59 | 49.38B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.11 | 44.89B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.21 | 35.96B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
487.25 | 21.36B | 3.08B | 1.24B | 1.07B | 25.61 |
Organogenesis Holdings Inc Stock (ORGO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-06-28 | Iniziato | Lake Street | Buy |
| 2024-02-07 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-06-15 | Iniziato | Morgan Stanley | Equal-Weight |
| 2023-05-24 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2022-11-10 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-08-10 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-01-10 | Iniziato | SVB Leerink | Outperform |
| 2019-08-26 | Ripresa | Credit Suisse | Outperform |
| 2019-05-02 | Iniziato | Credit Suisse | Outperform |
| 2019-04-17 | Iniziato | Oppenheimer | Outperform |
| 2019-04-11 | Iniziato | SunTrust | Buy |
Mostra tutto
Organogenesis Holdings Inc Borsa (ORGO) Ultime notizie
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis ... - Bluefield Daily Telegraph
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc.ORGO - FinancialContent
Organogenesis drops as Medicare to pull skin substitute LCDs (update) - MSN
Organogenesis Holdings extends leases for Canton facilities through 2032 By Investing.com - Investing.com Australia
Organogenesis Holdings extends leases for Canton facilities through 2032 - Investing.com
Organogenesis Extends Long-Term Leases for Key Facilities - TipRanks
Organogenesis (NASDAQ:ORGO) Shares Gap DownTime to Sell? - MarketBeat
Organogenesis' (ORGO) "Buy" Rating Reiterated at BTIG Research - MarketBeat
Organogenesis stock holds Buy rating at BTIG after CMS LCD decision - Investing.com
Organogenesis Initiates BLA Submission For ReNu In Knee Arthritis - Nasdaq
Organogenesis begins FDA rolling review for knee arthritis treatment By Investing.com - Investing.com Nigeria
Organogenesis starts rolling submission for ReNu allograft for knee arthritis - Seeking Alpha
Organogenesis stock rises after initiating FDA application for knee arthritis treatment By Investing.com - Investing.com South Africa
Organogenesis stock rises after initiating FDA application for knee arthritis treatment - Investing.com Nigeria
Organogenesis begins FDA rolling review for knee arthritis treatment - Investing.com
Organogenesis Announces Initiation of Biologics License Application for ReNu® - The Manila Times
Organogenesis Holdings Inc. Initiates Biologics License Application for ReNu® to Address Knee Osteoarthritis Pain - Quiver Quantitative
Biologic treatment for knee arthritis pain begins FDA license bid - Stock Titan
Gains Recap: Is Organogenesis Holdings Inc stock dividend yield sustainableWeekly Gains Report & Fast Gaining Stock Strategy Reports - moha.gov.vn
Net current asset value per share of Organogenesis Holdings, Inc. Class A – BER:2PQ - TradingView — Track All Markets
BTIG reiterates Organogenesis Holdings (ORGO) buy recommendation - MSN
Is Organogenesis Holdings Inc. stock a bargain at current levels2025 Momentum Check & Advanced Technical Analysis Signals - Улправда
Assenagon Asset Management S.A. Has $20.49 Million Stock Position in Organogenesis $ORGO - MarketBeat
Organogenesis (NASDAQ:ORGO) Shares Down 3.7% on Insider Selling - MarketBeat
Is Organogenesis Holdings Inc. stock dividend yield sustainableJuly 2025 Outlook & Breakout Confirmation Trade Signals - DonanımHaber
Is Organogenesis Holdings Inc. stock supported by strong cash flows2025 Price Targets & Free Safe Capital Growth Stock Tips - Улправда
Organogenesis (NASDAQ:ORGO) Director Glenn Nussdorf Sells 200,000 Shares - MarketBeat
Organogenesis Holdings Insider Sold Shares Worth $1,027,060, According to a Recent SEC Filing - marketscreener.com
Organogenesis Holdings Inc. (ORGO) director sells 200,000 shares - Stock Titan
How Organogenesis Holdings Inc. stock benefits from global expansion2025 Big Picture & Low Risk High Win Rate Stock Picks - Улправда
Organogenesis (NASDAQ:ORGO) Trading Up 8.5%Here's What Happened - MarketBeat
How Organogenesis Holdings Inc. stock reacts to oil pricesBreakout Watch & Consistent Return Strategy Ideas - Улправда
Recent Analysts’ Ratings Updates for Organogenesis (ORGO) - Defense World
Organogenesis (NASDAQ:ORGO) Earns “Buy” Rating from BTIG Research - Defense World
Organogenesis (NASDAQ:ORGO) Shares Gap UpTime to Buy? - MarketBeat
BTIG Research Reaffirms Buy Rating for Organogenesis (NASDAQ:ORGO) - MarketBeat
Organogenesis Plans to File Biologics Licenses Application for Knee Osteoarthritis Pain Therapy by 2025-End, Shares Up Pre-Bell - marketscreener.com
Organogenesis To File Rolling BLA For ReNu Following FDA Meeting - Nasdaq
Organogenesis Announces Successful FDA Meeting and Plan to File BLA for ReNu® for Knee Osteoarthritis Pain - The Manila Times
Organogenesis stock soars after FDA meeting clears path for ReNu BLA - Investing.com Nigeria
Organogenesis to submit rolling BLA for knee osteoarthritis treatment - Investing.com India
Organogenesis to submit rolling BLA for knee osteoarthritis treatment By Investing.com - Investing.com Australia
Organogenesis announces successful FDA meeting and plan to file BLA for ReNu® - marketscreener.com
Organogenesis (Nasdaq: ORGO) to file BLA for ReNu knee OA pain by Dec. 2025 - Stock Titan
December 2025's Top Penny Stocks With Promising Potential - simplywall.st
Organogenesis: High-Tech Skin Substitute Company On Sale (NASDAQ:ORGO) - Seeking Alpha
Investors in cash trouble should check out Organogenesis Holdings Inc (ORGO) - setenews.com
Why analysts remain bullish on Organogenesis Holdings Inc. stockEarnings Beat & Technical Entry and Exit Alerts - Newser
Is Organogenesis Holdings Inc. stock attractive for income investorsMarket Movers & Technical Buy Zone Confirmation - Newser
Organogenesis Holdings Inc. (NASDAQ:ORGO) Surges 29% Yet Its Low P/S Is No Reason For Excitement - 富途牛牛
Organogenesis Holdings Inc Azioni (ORGO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
8.30%
0.62%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):